microdroplets

The company said it will use the proceeds for, among other things, the continued development of its microdroplet-based single-molecule DNA sequencing technology.

Microfluidics firm Dolomite said this week that it has licensed microdroplet generation technology from the Japan Science and Technology Agency.

SUNY researchers are developing a droplet microfluidics device to extract mRNA from single cells, creating cDNA libraries in individual droplets for gene expression analysis.

RainDance also announced the commercial launch of the first product resulting from the collaboration: consumable chips for use on RainDance's RDT 1000 instrument for sequence enrichment and targeted sequencing applications.

The firm will use the funds to support development and commercialization efforts for new applications including single-molecule digital PCR and single-cell analysis.

The company claims that compared to other targeted sequence-enrichment methods, its approach leads to more uniform coverage, or less enrichment bias. RainDance said it plans to offer up to 4,000 amplifications in a single tube later this year.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.